Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegolsihematide for Anemia in Dialysis Patients
NCT02586402Phase 2Unknown
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Oct 2015
- Primary completion
- Aug 2016
- Modality
- PEGylated Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of peglmolesatide in anemia of chronic kidney disease (CKD-A), sponsored by Hansoh Pharmaceutical Group. Status: unknown.
02
Drugs
peglmolesatide
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02586402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02586402.